Enzyme analysis, in blood serum, measurement of the activity of specific enzymes in a sample of blood serum, usually for the purpose of identifying a disease. The enzymes that are used for the detection/diagnosis or prognosis of disease conditions are called “diagnostic enzymes.
Market Analysis and Insights: Global and United States In-vitro Diagnostics Enzymes Market
This report focuses on global and United States In-vitro Diagnostics Enzymes market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global In-vitro Diagnostics Enzymes market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Proteases accounting for % of the In-vitro Diagnostics Enzymes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharma & Biotech was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the In-vitro Diagnostics Enzymes market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global In-vitro Diagnostics Enzymes Scope and Market Size
In-vitro Diagnostics Enzymes market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global In-vitro Diagnostics Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the In-vitro Diagnostics Enzymes market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Proteases
Polymerase & Transcriptase
Ribonuclease
Others
Segment by Application
Pharma & Biotech
Hospital & Diagnostic Labs
Contract Research Organizations (CROs)
Academic Labs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Merck KGaA
Codexis, Inc.
F. Hoffmann-La Roche Ltd.
Amano Enzyme Inc.
Advanced Enzymes Technologies Ltd.
Biocatalysts Ltd.
Amicogen
Dyadic International
BBI Solutions
Affymetrix
American Laboratories